How much funding has Marea Therapeutics raised?

Marea Therapeutics has raised $190.0M in total funding, most recently a Series A round.

When was Marea Therapeutics founded?

Marea Therapeutics was founded in 2024.

Where is Marea Therapeutics headquartered?

Marea Therapeutics is headquartered in South San Francisco, California, United States.

What industry is Marea Therapeutics in?

Marea Therapeutics operates in Biotech, Healthcare.

How many employees does Marea Therapeutics have?

Marea Therapeutics has 11-50 employees.

Marea Therapeutics

Q: Who are Marea Therapeutics's investors?

Marea Therapeutics's investors include Sofinnova Investments, Third Rock Ventures, Forbion Capital Partners.

South San Francisco, United States · Founded 2024 · $190.0M raised

Biotech

Healthcare

Headquarters: South San Francisco, California
Employees: 11–50
Founded: 2024
Business Model: B2B

Website: mareatx.com
Total Funding: $190.0M
Last Round: Series AJun 2024
Rounds: 2

About

Marea Therapeutics is a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardioendocrine diseases. Incubated by Third Rock Ventures and launched in 2024, the company's lead program MAR001 is in Phase 2 clinical development for adults with metabolic dysfunction and high cardiovascular risk, while MAR002 is advancing toward the clinic for acromegaly. The company is headquartered in South San Francisco and led by a team of scientists and biopharma executives with deep expertise in cardioendocrine biology and human genetics.

Summary

Marea Therapeutics is a Biotech company based in South San Francisco, United States, founded in 2024. It has raised $190.0M in total across 2 rounds, most recently a Series A round in Jun 2024. Investors include Sofinnova Investments, Third Rock Ventures and Forbion Capital Partners.